Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- Check3 days agoChange DetectedAn NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe update adds a Revision: v3.7.0 tag. It also removes a broad set of metadata, search terms, and historical entries from the page, affecting navigation and related context rather than the study details.SummaryDifference20%

- Check59 days agoChange DetectedThe page now shows the correctly spelled Cantonal Hospital, Baselland, replacing the previous misspelling; it also updates the revision label from v3.6.5 to v3.6.6, indicating a newer version of the document.SummaryDifference0.3%

- Check65 days agoChange DetectedThere are no recorded textual changes for this page; the study details, eligibility, and outcomes appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.